Education
About Us
Working with TipRanks
Follow Us
Mersana Therapeutics Inc (MRSN)
NASDAQ:MRSN
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 40.50M | $ 36.85M | $ 26.58M | $ 43.00K | $ 828.00K |
| Gross Profit | $ 40.50M | $ -111.41M | $ 25.65M | $ -131.97M | $ -66.21M |
| Operating Income | $ -73.34M | $ -170.96M | $ -204.69M | $ -169.71M | $ -87.69M |
| EBITDA | $ -63.27M | $ -166.08M | $ -199.96M | $ -167.94M | $ -86.68M |
| Net Income | $ -69.19M | $ -171.67M | $ -207.54M | $ -169.21M | $ -88.40M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 134.62M | $ 209.08M | $ 280.71M | $ 177.95M | $ 255.09M |
| Total Assets | $ 144.66M | $ 226.06M | $ 334.34M | $ 206.11M | $ 273.40M |
| Total Debt | $ 17.65M | $ 33.83M | $ 36.30M | $ 38.18M | $ 16.57M |
| Net Debt | $ -90.10M | $ -140.73M | $ -244.41M | $ -139.77M | $ -238.52M |
| Total Liabilities | $ 154.17M | $ 189.16M | $ 242.28M | $ 84.37M | $ 45.31M |
| Stockholders' Equity | $ -9.51M | $ 36.90M | $ 92.06M | $ 121.74M | $ 228.09M |
| Cash Flow | |||||
| Free Cash Flow | $ -82.47M | $ -171.05M | $ -51.56M | $ -140.64M | $ -75.17M |
| Operating Cash Flow | $ -82.34M | $ -168.88M | $ -49.36M | $ -139.99M | $ -74.70M |
| Investing Cash Flow | $ 11.44M | $ 119.88M | $ -152.72M | $ -648.00K | $ 37.03M |
| Financing Cash Flow | $ 4.09M | $ 94.67M | $ 153.02M | $ 63.65M | $ 230.41M |